liu.seSearch for publications in DiVA
Planned maintenance
A system upgrade is planned for 17/11-2026, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden.
Uppsala Univ, Sweden; Uppsala Univ, Sweden.
Reg Canc Ctr South, Sweden.
Dept Oncol, Sweden.
Show others and affiliations
2021 (English)In: eJHaem, E-ISSN 2688-6146, Vol. 2, no 3, p. 400-412Article in journal (Refereed) Published
Abstract [en]

Treatment for patients > 60 years with classical Hodgkin lymphoma (cHL) is problematic; there is no gold standard, and outcome is poor. Using the Swedish Lymphoma Registry, we analysed all Swedish patients diagnosed with cHL between 2000 and 2014 (N = 2345; median age 42 years; 691 patients were >60 years). The median follow-up time was 6.7 years. Treatment for elderly patients consisted mainly of ABVD or CHOP, and the younger patients were treated with ABVD or BEACOPP (with no survival difference). In multivariable analysis of patients > 60 years, ABVD correlated with better survival than CHOP (p = 0.027), and ABVD became more common over time among patients aged 61-70 years (p = 0.0206). Coinciding with the implementation of FDG-PET/CT, the fraction of advanced-stage disease increased in later calendar periods, also in the older patient group. Survival has improved in cHL patients > 60 years (p = 0.027), for whom ABVD seems superior to CHOP.

Place, publisher, year, edition, pages
WILEY , 2021. Vol. 2, no 3, p. 400-412
Keywords [en]
classical Hodgkin lymphoma; older patients; population-based; survival; treatment
National Category
Surgery
Identifiers
URN: urn:nbn:se:liu:diva-209565DOI: 10.1002/jha2.202ISI: 001228423000041PubMedID: 35844675OAI: oai:DiVA.org:liu-209565DiVA, id: diva2:1913224
Note

Funding Agencies|Cancerfonden; Svenska Sallskapet for Medicinsk Forskning (SSMF); Stockholm County Council; Stiftelsen Onkologiska Klinikens i Uppsala Cancerforskningsfond; Lion's Cancerforskningsfond vid Akademiska sjukhuset

Available from: 2024-11-14 Created: 2024-11-14 Last updated: 2025-05-01

Open Access in DiVA

fulltext(659 kB)61 downloads
File information
File name FULLTEXT01.pdfFile size 659 kBChecksum SHA-512
91b0709a9aca49c67929d958b0599ad546a2b204efd0e89cec5407112befd3ae34bc312e316ff031ac095857095cff46381feb9358796c652156820b58d9fba4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lagerlöf, Ingemar
By organisation
Department of Biomedical and Clinical SciencesFaculty of Medicine and Health SciencesDepartment of Haematology
In the same journal
eJHaem
Surgery

Search outside of DiVA

GoogleGoogle Scholar
Total: 61 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 110 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf